Primordial Genetics Inc has launched its laboratory operations at the JLABS biotechnology incubator on July 19, 2013. The company obtained seed funding from a private investor as well as a Phase I grant from the National Science Foundation. The funds will be used to conduct proof-of-concept work in the baker’s yeast Saccharomyces cerevisiae, to develop novel strains highly resistant to alcohols and environmental stresses for use in fermentation and production of fuels and chemicals.
Related Articles
-
Primordial Genetics and Denovium Collaborate to Impact the Diagnosis, Prevention & Treatment of Human Diseases
The Research is Supported by the National Human Genome Research Institute of the National Institutes of Health Primordial Genetics,...
-
The Science ‘Rebel’ Who’s Teaching Microbes to be More Productive
On this episode of the J&J Innovation Podcast, we sit down with Helge Zieler, founder and President of Primordial Genetics, about...
-
Primordial Genetics receives Notice of Allowance from USPTO covering Function Generator combinatorial genetics technology.
Primordial Genetics is pleased to announce that the United States Patent and Trademark Office has issued a Notice of...
-
-
Primordial Genetics receives NIH Grant: Synthetic biology E. coli strain development for expression of functional human GPCRs with roles in human disease
The principal aim of this project is to apply a novel synthetic biology approach to develop protein expression strains...
-
Primordial Genetics and Bayer announce research collaboration to enhance crop performance
Primordial Genetics and Bayer CropScience LP announced today the establishment of a research collaboration to evaluate Primordial Genetics’ proprietary...
-
-
Poster Presentation at Synbiobeta Conference by Sabrina German
Sabrina German of Primordial Genetics Inc. won an award for best poster at Synbiobeta, San Francisco, CA Oct 5....
0 Comments